Industry Growth Insights published a new data on “Glass Pre-Filled Syringe Market”. The research report is titled “Glass Pre-Filled Syringe Market research by Types (1ml-5ml, 5ml-10ml, >10ml), By Applications (Vaccines, Monoclonal Antibodies), By Players/Companies BD, Gerresheimer, Schott, Baxter, Nipro, Ompi (Stevanato Group), Weigao, Unilife, Roselabs, Vetter Pharma, National Medical Products, Robert Bosch GmbH, Owen Mumford, Ypsomed, SHL Group, Bespak, ROVI CM, Terumo, Taisei Kako, ARTE CORPORATION”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Glass Pre-Filled Syringe Market Research Report
By Type
1ml-5ml, 5ml-10ml, >10ml
By Application
Vaccines, Monoclonal Antibodies
By Companies
BD, Gerresheimer, Schott, Baxter, Nipro, Ompi (Stevanato Group), Weigao, Unilife, Roselabs, Vetter Pharma, National Medical Products, Robert Bosch GmbH, Owen Mumford, Ypsomed, SHL Group, Bespak, ROVI CM, Terumo, Taisei Kako, ARTE CORPORATION
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Glass Pre-Filled Syringe Market Report Segments:
The global Glass Pre-Filled Syringe market is segmented on the basis of:
Types
1ml-5ml, 5ml-10ml, >10ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vaccines, Monoclonal Antibodies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Gerresheimer
- Schott
- Baxter
- Nipro
- Ompi (Stevanato Group)
- Weigao
- Unilife
- Roselabs
- Vetter Pharma
- National Medical Products
- Robert Bosch GmbH
- Owen Mumford
- Ypsomed
- SHL Group
- Bespak
- ROVI CM
- Terumo
- Taisei Kako
- ARTE CORPORATION
Highlights of The Glass Pre-Filled Syringe Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1ml-5ml
- 5ml-10ml
- >10ml
- By Application:
- Vaccines
- Monoclonal Antibodies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glass Pre-Filled Syringe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A glass pre-filled syringe is a medical device that uses a needle to inject medication or other substances into the body.
Some of the major companies in the glass pre-filled syringe market are BD, Gerresheimer, Schott, Baxter, Nipro, Ompi (Stevanato Group), Weigao, Unilife, Roselabs, Vetter Pharma, National Medical Products, Robert Bosch GmbH, Owen Mumford, Ypsomed, SHL Group, Bespak, ROVI CM, Terumo, Taisei Kako, ARTE CORPORATION.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Glass Pre-Filled Syringe Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glass Pre-Filled Syringe Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glass Pre-Filled Syringe Market - Supply Chain
4.5. Global Glass Pre-Filled Syringe Market Forecast
4.5.1. Glass Pre-Filled Syringe Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glass Pre-Filled Syringe Market Size (000 Units) and Y-o-Y Growth
4.5.3. Glass Pre-Filled Syringe Market Absolute $ Opportunity
5. Global Glass Pre-Filled Syringe Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Glass Pre-Filled Syringe Market Size and Volume Forecast by Type
5.3.1. 1ml-5ml
5.3.2. 5ml-10ml
5.3.3. >10ml
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Glass Pre-Filled Syringe Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Glass Pre-Filled Syringe Market Size and Volume Forecast by Application
6.3.1. Vaccines
6.3.2. Monoclonal Antibodies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Glass Pre-Filled Syringe Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Glass Pre-Filled Syringe Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Glass Pre-Filled Syringe Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Glass Pre-Filled Syringe Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Glass Pre-Filled Syringe Demand Share Forecast, 2019-2026
9. North America Glass Pre-Filled Syringe Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Glass Pre-Filled Syringe Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Glass Pre-Filled Syringe Market Size and Volume Forecast by Application
9.4.1. Vaccines
9.4.2. Monoclonal Antibodies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Glass Pre-Filled Syringe Market Size and Volume Forecast by Type
9.7.1. 1ml-5ml
9.7.2. 5ml-10ml
9.7.3. >10ml
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Glass Pre-Filled Syringe Demand Share Forecast, 2019-2026
10. Latin America Glass Pre-Filled Syringe Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Glass Pre-Filled Syringe Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Glass Pre-Filled Syringe Market Size and Volume Forecast by Application
10.4.1. Vaccines
10.4.2. Monoclonal Antibodies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Glass Pre-Filled Syringe Market Size and Volume Forecast by Type
10.7.1. 1ml-5ml
10.7.2. 5ml-10ml
10.7.3. >10ml
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Glass Pre-Filled Syringe Demand Share Forecast, 2019-2026
11. Europe Glass Pre-Filled Syringe Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Glass Pre-Filled Syringe Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Glass Pre-Filled Syringe Market Size and Volume Forecast by Application
11.4.1. Vaccines
11.4.2. Monoclonal Antibodies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Glass Pre-Filled Syringe Market Size and Volume Forecast by Type
11.7.1. 1ml-5ml
11.7.2. 5ml-10ml
11.7.3. >10ml
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projctions by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Glass Pre-Filled Syringe Demand Share, 2019-2026
12. Asia Pacific Glass Pre-Filled Syringe Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Glass Pre-Filled Syringe Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Glass Pre-Filled Syringe Market Size and Volume Forecast by Application
12.4.1. Vaccines
12.4.2. Monoclonal Antibodies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Glass Pre-Filled Syringe Market Size and Volume Forecast by Type
12.7.1. 1ml-5ml
12.7.2. 5ml-10ml
12.7.3. >10ml
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Glass Pre-Filled Syringe Demand Share, 2019-2026
13. Middle East & Africa Glass Pre-Filled Syringe Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Glass Pre-Filled Syringe Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Glass Pre-Filled Syringe Market Size and Volume Forecast by Application
13.4.1. Vaccines
13.4.2. Monoclonal Antibodies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Glass Pre-Filled Syringe Market Size and Volume Forecast by Type
13.7.1. 1ml-5ml
13.7.2. 5ml-10ml
13.7.3. >10ml
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Glass Pre-Filled Syringe Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Glass Pre-Filled Syringe Market: Market Share Analysis
14.2. Glass Pre-Filled Syringe Distributors and Customers
14.3. Glass Pre-Filled Syringe Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Gerresheimer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Schott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Baxter
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nipro
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ompi (Stevanato Group)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Weigao
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Unilife
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Roselabs
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Vetter Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. National Medical Products
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Robert Bosch GmbH
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Owen Mumford
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Ypsomed
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. SHL Group
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Bespak
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. ROVI CM
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Terumo
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Taisei Kako
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. ARTE CORPORATION
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
